Targeting High-Density Lipoproteins: Increasing De Novo Production Versus Decreasing Clearance Arshag D. MooradianMichael J. Haas Current Opinion 21 April 2015 Pages: 713 - 722
Antisense Approach to Inflammatory Bowel Disease: Prospects and Challenges Irene MarafiniDavide Di FuscoGiovanni Monteleone Leading Article 25 April 2015 Pages: 723 - 730
Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status Marc PeetersMeinolf KarthausJean-Yves Douillard Review Article Open access 21 April 2015 Pages: 731 - 748
Disease Modification in Epilepsy: From Animal Models to Clinical Applications Melissa L. Barker-HaliskiDan FriedmanH. Steve White Review Article 30 April 2015 Pages: 749 - 767
Ibrutinib: A Review of Its Use in Patients with Mantle Cell Lymphoma or Chronic Lymphocytic Leukaemia Esther S. KimSohita Dhillon Adis Drug Evaluation 24 March 2015 Pages: 769 - 776
Alogliptin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus Gillian M. Keating Adis Drug Evaluation 09 April 2015 Pages: 777 - 796
Vorapaxar: A Review of Its Use in the Long-Term Secondary Prevention of Atherothrombotic Events James E. Frampton Adis Drug Evaluation 21 April 2015 Pages: 797 - 808
Tiotropium Respimat®: A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β2-Adrenergic Agonists Kate McKeage Adis Drug Evaluation 21 April 2015 Pages: 809 - 816
Isavuconazonium: First Global Approval Paul L. McCormack R&D Insight Report 23 April 2015 Pages: 817 - 822